An institutional thesis for GCC healthcare.
We deploy patient capital into category-defining consumer health brands aligned with Saudi Vision 2030 and the broader GCC growth corridor.
The Gulf consumer is moving up-market. Premium health is the next category to follow.
Green Path Medica is positioned at the intersection of three durable tailwinds: rising disposable income, sovereign localization mandates, and global brand demand for serious Gulf operating partners.
Patient capital
Multi-decade ownership horizons aligned with the longevity of premium consumer health brands.
Brand stewardship
Operating model that protects heritage equity while engineering regional category leadership.
Localized supply
Integrated Saudi manufacturing under Vision 2030's industrial localization framework.
Cross-border M&A
Selective acquisition of European laboratories with category-defining science.
Investor Access Request
For family offices, sovereign capital, and institutional allocators. Submit your institutional email and Investor Relations will respond directly.